The Multiple Sclerosis Continuous Quality Improvement (MSCQI) Collaborative
| Status: | Recruiting |
|---|---|
| Conditions: | Neurology, Neurology, Multiple Sclerosis |
| Therapuetic Areas: | Neurology, Other |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/6/2019 |
| Start Date: | July 1, 2017 |
| End Date: | December 31, 2021 |
| Contact: | Amy E Hall, MS |
| Email: | amy.e.hall@hitchcock.org |
| Phone: | 603-653-6871 |
Improving Quality and Value of Multiple Sclerosis Care at the Microsystem Level: The Multiple Sclerosis Continuous Quality Improvement (MSCQI) Collaborative
To establish the first systems level continuous quality improvement (CQI) collaborative for
multiple sclerosis (MS) in the United States, to conduct benchmarking analyses and
assessments of geographic variation in MS care quality and value, and study the effect of CQI
interventions on improvement of selected performance (quality) indicators.
multiple sclerosis (MS) in the United States, to conduct benchmarking analyses and
assessments of geographic variation in MS care quality and value, and study the effect of CQI
interventions on improvement of selected performance (quality) indicators.
This is a three year study which will employ a step-wedge randomized design which will expose
three of four participating centers to a healthcare QI intervention during the 3 year period.
Each of the centers exposed to an intervention will serve as its own control during a
baseline pre-intervention period during the first year of the study. The fourth site will
serve as a longitudinal control for comparison to the other three centers exposed to a QI
intervention.
three of four participating centers to a healthcare QI intervention during the 3 year period.
Each of the centers exposed to an intervention will serve as its own control during a
baseline pre-intervention period during the first year of the study. The fourth site will
serve as a longitudinal control for comparison to the other three centers exposed to a QI
intervention.
Inclusion Criteria:
- Adults aged 18 years or older with documented clinically confirmed MS who are followed
by one of the participating MS centers.
Exclusion Criteria:
- Candidates will be excluded from study entry if they are unable or unwilling to
provide informed consent.
We found this trial at
4
sites
Click here to add this to my saved trials
Boston, Massachusetts 02114
Principal Investigator: Eric Klawiter, MD
Phone: 617-724-3133
Click here to add this to my saved trials
Burlington, Vermont 05401
Principal Investigator: Andrew Solomon, MD
Phone: 802-847-4589
Click here to add this to my saved trials
Maitland, Florida 32751
Principal Investigator: Patricia Pagnotta, ARNP
Phone: 407-647-5996
Click here to add this to my saved trials